|
|
转移性肺癌与肿瘤相关性抑郁之间影响因素的研究进展
|
Abstract:
转移性肺癌指任何部位的恶性肿瘤通过各种转移方式转移至肺部的肿瘤，在经历多线化疗、放疗、免疫及靶向治疗后，患者往往存在着心理上负担，从而患上抑郁症，导致肿瘤的治疗效果不尽人意。本文针对转移性肺癌与抑郁之间的影响因素进行综述，探求原因，以期为临床转移性肺癌患者抑郁症的治疗提供相关思路。
Metastatic lung cancer refers to tumors that have metastasized to the lungs through various metastatic modalities from malignant tumors in any part of the body. After undergoing multiple lines of chemotherapy, radiotherapy, immunotherapy and targeted therapy, patients are often psychologically burdened, and thus suffer from depression, which leads to unsatisfactory treatment results of the tumors. This paper reviews the influencing factors between metastatic lung cancer and depression and explores the causes, with a view to providing relevant ideas for the treatment of depression in clinical metastatic lung cancer patients.
| [1] | Götze, H., Friedrich, M., Taubenheim, S., Dietz, A., Lordick, F. and Mehnert, A. (2019) Depression and Anxiety in Long-Term Survivors 5 and 10 Years after Cancer Diagnosis. Supportive Care in Cancer, 28, 211-220. https://doi.org/10.1007/s00520-019-04805-1 |
| [2] | Sullivan, D.R., Forsberg, C.W., Ganzini, L., Au, D.H., Gould, M.K., Provenzale, D., et al. (2016) Longitudinal Changes in Depression Symptoms and Survival among Patients with Lung Cancer: A National Cohort Assessment. Journal of Clinical Oncology, 34, 3984-3991. https://doi.org/10.1200/jco.2016.66.8459 |
| [3] | Morrison, E.J., Novotny, P.J., Sloan, J.A., Yang, P., Patten, C.A., Ruddy, K.J., et al. (2017) Emotional Problems, Quality of Life, and Symptom Burden in Patients with Lung Cancer. Clinical Lung Cancer, 18, 497-503. https://doi.org/10.1016/j.cllc.2017.02.008 |
| [4] | Leung, B., Laskin, J., Wu, J., Bates, A. and Ho, C. (2019) Assessing the Psychosocial Needs of Newly Diagnosed Patients with Nonsmall Cell Lung Cancer: Identifying Factors Associated with Distress. Psycho-Oncology, 28, 815-821. https://doi.org/10.1002/pon.5025 |
| [5] | Pan, L.A., Martin, P., Zimmer, T., Segreti, A.M., Kassiff, S., McKain, B.W., et al. (2017) Neurometabolic Disorders: Potentially Treatable Abnormalities in Patients with Treatment-Refractory Depression and Suicidal Behavior. American Journal of Psychiatry, 174, 42-50. https://doi.org/10.1176/appi.ajp.2016.15111500 |
| [6] | Didkowska, J., Wojciechowska, U., Mańczuk, M. and Łobaszewski, J. (2016) Lung Cancer Epidemiology: Contemporary and Future Challenges Worldwide. Annals of Translational Medicine, 4, 150-150. https://doi.org/10.21037/atm.2016.03.11 |
| [7] | Walker, J., Hansen, C.H., Martin, P., Symeonides, S., Ramessur, R., Murray, G., et al. (2014) Prevalence, Associations, and Adequacy of Treatment of Major Depression in Patients with Cancer: A Cross-Sectional Analysis of Routinely Collected Clinical Data. The Lancet Psychiatry, 1, 343-350. https://doi.org/10.1016/s2215-0366(14)70313-x |
| [8] | Dai, J., Liao, N., Shi, J. and Tao, J.Q. (2017) Study of Prevalence and Influencing Factors of Depression in Tumor Patients and the Therapeutic Effects of Fluoxetine. European Review for Medical and Pharmacological Sciences, 21, 4966-4974. |
| [9] | Kroenke, K., Spitzer, R.L. and Williams, J.B.W. (2001) The PHQ-9. Journal of General Internal Medicine, 16, 606-613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x |
| [10] | Manea, L., Gilbody, S. and McMillan, D. (2011) Optimal Cut-Off Score for Diagnosing Depression with the Patient Health Questionnaire (PHQ-9): A Meta-Analysis. Canadian Medical Association Journal, 184, E191-E196. https://doi.org/10.1503/cmaj.110829 |
| [11] | Annunziata, M.A., Muzzatti, B., Bidoli, E., Flaiban, C., Bomben, F., Piccinin, M., et al. (2019) Hospital Anxiety and Depression Scale (HADS) Accuracy in Cancer Patients. Supportive Care in Cancer, 28, 3921-3926. https://doi.org/10.1007/s00520-019-05244-8 |
| [12] | Wu, Y., Levis, B., Sun, Y., He, C., Krishnan, A., Neupane, D., et al. (2021) Accuracy of the Hospital Anxiety and Depression Scale Depression Subscale (HADS-D) to Screen for Major Depression: Systematic Review and Individual Participant Data Meta-Analysis. BMJ, 373, n972. https://doi.org/10.1136/bmj.n972 |
| [13] | Richter, P., Werner, J., Heerlein, A., Kraus, A. and Sauer, H. (1998) On the Validity of the Beck Depression Inventory. Psychopathology, 31, 160-168. https://doi.org/10.1159/000066239 |
| [14] | Zung, W.W.K. (1965) A Self-Rating Depression Scale. Archives of General Psychiatry, 12, 63-70. https://doi.org/10.1001/archpsyc.1965.01720310065008 |
| [15] | Dunstan, D.A., Scott, N. and Todd, A.K. (2017) Screening for Anxiety and Depression: Reassessing the Utility of the Zung Scales. BMC Psychiatry, 17, Article No. 329. https://doi.org/10.1186/s12888-017-1489-6 |
| [16] | Sotelo, J.L., Musselman, D. and Nemeroff, C. (2014) The Biology of Depression in Cancer and the Relationship between Depression and Cancer Progression. International Review of Psychiatry, 26, 16-30. https://doi.org/10.3109/09540261.2013.875891 |
| [17] | Strawbridge, R., Arnone, D., Danese, A., Papadopoulos, A., Herane Vives, A. and Cleare, A.J. (2015) Inflammation and Clinical Response to Treatment in Depression: A Meta-Analysis. European Neuropsychopharmacology, 25, 1532-1543. https://doi.org/10.1016/j.euroneuro.2015.06.007 |
| [18] | Akil, H., Gordon, J., Hen, R., Javitch, J., Mayberg, H., McEwen, B., et al. (2018) Treatment Resistant Depression: A Multi-Scale, Systems Biology Approach. Neuroscience & Biobehavioral Reviews, 84, 272-288. https://doi.org/10.1016/j.neubiorev.2017.08.019 |
| [19] | McFarland, D.C., Jutagir, D.R., Rosenfeld, B., Pirl, W., Miller, A.H., Breitbart, W., et al. (2019) Depression and Inflammation among Epidermal Growth Factor Receptor (EGFR) Mutant Nonsmall Cell Lung Cancer Patients. Psycho-Oncology, 28, 1461-1469. https://doi.org/10.1002/pon.5097 |
| [20] | McFarland, D.C., Breitbart, W., Miller, A.H. and Nelson, C. (2020) Depression and Inflammation in Patients with Lung Cancer: A Comparative Analysis of Acute Phase Reactant Inflammatory Markers. Psychosomatics, 61, 527-537. https://doi.org/10.1016/j.psym.2020.03.005 |
| [21] | Giannousi, Z., Gioulbasanis, I., Pallis, A.G., Xyrafas, A., Dalliani, D., Kalbakis, K., et al. (2011) Nutritional Status, Acute Phase Response and Depression in Metastatic Lung Cancer Patients: Correlations and Association Prognosis. Supportive Care in Cancer, 20, 1823-1829. https://doi.org/10.1007/s00520-011-1282-x |
| [22] | Colotta, F., Allavena, P., Sica, A., Garlanda, C. and Mantovani, A. (2009) Cancer-Related Inflammation, the Seventh Hallmark of Cancer: Links to Genetic Instability. Carcinogenesis, 30, 1073-1081. https://doi.org/10.1093/carcin/bgp127 |
| [23] | Kappelmann, N., Lewis, G., Dantzer, R., Jones, P.B. and Khandaker, G.M. (2016) Antidepressant Activity of Anti-Cytokine Treatment: A Systematic Review and Meta-Analysis of Clinical Trials of Chronic Inflammatory Conditions. Molecular Psychiatry, 23, 335-343. https://doi.org/10.1038/mp.2016.167 |
| [24] | Chen, X., DuBois, D.C., Almon, R.R. and Jusko, W.J. (2017) Interrelationships between Infliximab and Recombinant Tumor Necrosis Factor-αin Plasma Using Minimal Physiologically Based Pharmacokinetic Models. Drug Metabolism and Disposition, 45, 790-797. https://doi.org/10.1124/dmd.116.074807 |
| [25] | Hung, K.C., Wu, C.C., Chen, H.S., Ma, W.Y., Tseng, C.F., Yang, L.K., et al. (2010) Serum IL-6, Albumin and Comorbidities Are Closely Correlated with Symptoms of Depression in Patients on Maintenance Haemodialysis. Nephrology Dialysis Transplantation, 26, 658-664. https://doi.org/10.1093/ndt/gfq411 |
| [26] | Valkanova, V., Ebmeier, K.P. and Allan, C.L. (2013) CRP, IL-6 and Depression: A Systematic Review and Meta-Analysis of Longitudinal Studies. Journal of Affective Disorders, 150, 736-744. https://doi.org/10.1016/j.jad.2013.06.004 |
| [27] | Jha, M. and Trivedi, M. (2018) Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation. International Journal of Molecular Sciences, 19, Article 233. https://doi.org/10.3390/ijms19010233 |
| [28] | Howren, M.B., Lamkin, D.M. and Suls, J. (2009) Associations of Depression with C-Reactive Protein, IL-1, and IL-6: A Meta-analysis. Psychosomatic Medicine, 71, 171-186. https://doi.org/10.1097/psy.0b013e3181907c1b |
| [29] | Goel, P., Kulkarni, K., Rashmi, N., Galhotra, V., Rajguru, J.P. and Jha, S.K. (2017) Assessment of C-Reactive Proteins, Cytokines, and Plasma Protein Levels in Hypertensive Patients with Apical Periodontitis. The Journal of Contemporary Dental Practice, 18, 516-521. https://doi.org/10.5005/jp-journals-10024-2076 |
| [30] | Jin, J., Hu, K., Zhou, Y. and Li, W. (2017) Clinical Utility of the Modified Glasgow Prognostic Score in Lung Cancer: A Meta-analysis. PLOS ONE, 12, e0184412. https://doi.org/10.1371/journal.pone.0184412 |
| [31] | Shrotriya, S., Walsh, D., Nowacki, A.S., Lorton, C., Aktas, A., Hullihen, B., et al. (2018) Serum C-Reactive Protein Is an Important and Powerful Prognostic Biomarker in Most Adult Solid Tumors. PLOS ONE, 13, e0202555. https://doi.org/10.1371/journal.pone.0202555 |
| [32] | McFarland, D.C., Miller, A.H. and Nelson, C. (2020) A Longitudinal Analysis of Inflammation and Depression in Patients with Metastatic Lung Cancer: Associations with Survival. Biological Research for Nursing, 23, 301-310. https://doi.org/10.1177/1099800420959721 |
| [33] | McFarland, D.C., Fernbach, M., Breitbart, W.S. and Nelson, C. (2020) Prognosis in Metastatic Lung Cancer: Vitamin D Deficiency and Depression—A Cross-Sectional Analysis. BMJ Supportive & Palliative Care, 12, 339-346. https://doi.org/10.1136/bmjspcare-2020-002457 |
| [34] | Jha, M.K., Minhajuddin, A., Gadad, B.S., Greer, T., Grannemann, B., Soyombo, A., et al. (2017) Can C-Reactive Protein Inform Antidepressant Medication Selection in Depressed Outpatients? Findings from the CO-MED Trial. Psychoneuroendocrinology, 78, 105-113. https://doi.org/10.1016/j.psyneuen.2017.01.023 |
| [35] | McFarland, D.C., Jutagir, D.R., Miller, A.H., Breitbart, W., Nelson, C. and Rosenfeld, B. (2020) Tumor Mutation Burden and Depression in Lung Cancer: Association with Inflammation. Journal of the National Comprehensive Cancer Network, 18, 434-442. https://doi.org/10.6004/jnccn.2019.7374 |
| [36] | de Oliveira, C., Hirani, V. and Biddulph, J.P. (2017) Associations between Vitamin D Levels and Depressive Symptoms in Later Life: Evidence from the English Longitudinal Study of Ageing (ELSA). The Journals of Gerontology: Series A, 73, 1377-1382. https://doi.org/10.1093/gerona/glx130 |
| [37] | An, E., Lo, C., Hales, S., Zimmermann, C. and Rodin, G. (2018) Demoralization and Death Anxiety in Advanced Cancer. Psycho-Oncology, 27, 2566-2572. https://doi.org/10.1002/pon.4843 |
| [38] | Grossman, C.H., Brooker, J., Michael, N. and Kissane, D. (2017) Death Anxiety Interventions in Patients with Advanced Cancer: A Systematic Review. Palliative Medicine, 32, 172-184. https://doi.org/10.1177/0269216317722123 |
| [39] | Eggen, A.C., Reyners, A.K.L., Shen, G., Bosma, I., Jalving, M., Leighl, N.B., et al. (2020) Death Anxiety in Patients with Metastatic Non-Small Cell Lung Cancer with and without Brain Metastases. Journal of Pain and Symptom Management, 60, 422-429.e1. https://doi.org/10.1016/j.jpainsymman.2020.02.023 |
| [40] | Pyszczynski, T., Greenberg, J., Solomon, S., Arndt, J. and Schimel, J. (2004) Why Do People Need Self-Esteem? A Theoretical and Empirical Review. Psychological Bulletin, 130, 435-468. https://doi.org/10.1037/0033-2909.130.3.435 |
| [41] | Rodin, G., Lo, C., Rydall, A., Shnall, J., Malfitano, C., Chiu, A., et al. (2018) Managing Cancer and Living Meaningfully (CALM): A Randomized Controlled Trial of a Psychological Intervention for Patients with Advanced Cancer. Journal of Clinical Oncology, 36, 2422-2432. https://doi.org/10.1200/jco.2017.77.1097 |
| [42] | Devins, G.M. (2010) Using the Illness Intrusiveness Ratings Scale to Understand Health-Related Quality of Life in Chronic Disease. Journal of Psychosomatic Research, 68, 591-602. https://doi.org/10.1016/j.jpsychores.2009.05.006 |
| [43] | Gonzalez-Ling, A., Galindo Vázquez, O., Espinoza Bello, M., Robles, R., Rascón-Gasca, M.L., Lara-Mejía, L., et al. (2022) Quality of Life, Anxiety, Depression, and Distress in Patients with Advanced and Metastatic Lung Cancer. Palliative and Supportive Care, 21, 608-615. https://doi.org/10.1017/s147895152200116x |
| [44] | McFarland, D.C. (2020) A Response to “Psychological Symptoms and Survival in Patients with Metastatic Lung Cancer: Smoking Must Be the First Concern!”. Psycho-Oncology, 29, 1504-1505. https://doi.org/10.1002/pon.5405 |
| [45] | LeBlanc, T.W., Samsa, G.P., Wolf, S.P., Locke, S.C., Cella, D.F. and Abernethy, A.P. (2015) Validation and Real-World Assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) Scale in Patients with Advanced Non-Small Cell Lung Cancer and the Cancer Anorexia-Cachexia Syndrome (CACS). Supportive Care in Cancer, 23, 2341-2347. https://doi.org/10.1007/s00520-015-2606-z |
| [46] | Chabowski, M., Polański, J., Jankowska-Polańska, B., Janczak, D. and Rosińczuk, J. (2018) Is Nutritional Status Associated with the Level of Anxiety, Depression and Pain in Patients with Lung Cancer? Journal of Thoracic Disease, 10, 2303-2310. https://doi.org/10.21037/jtd.2018.03.108 |
| [47] | McFarland, D.C., Nelson, C. and Miller, A.H. (2020) Early Childhood Adversity in Adult Patients with Metastatic Lung Cancer: Cross-Sectional Analysis of Symptom Burden and Inflammation. Brain, Behavior, and Immunity, 90, 167-173. https://doi.org/10.1016/j.bbi.2020.08.006 |
| [48] | Siegel, R.L., Miller, K.D. and Jemal, A. (2019) Cancer Statistics, 2019. CA: A Cancer Journal for Clinicians, 69, 7-34. https://doi.org/10.3322/caac.21551 |
| [49] | McFarland, D.C., Jutagir, D.R., Rosenfeld, B. and Nelson, C.J. (2019) Physiological and Psychological Associations of Early Childhood Adversity in Lung Cancer. Journal of Clinical Oncology, 37, 80. https://doi.org/10.1200/jco.2019.37.31_suppl.80 |
